www.prnewswire.com
2026-06-23
SandboxAQ has launched a virtual screening solution for GPCR drug discovery, accelerated by NVIDIA's BioNeMo Agent Toolkit. GPCRs, which represent about one-third of all approved drugs, are notoriously difficult to target due to their dynamic conformational states. The new solution predicts not only